PAVM PAVmed Inc.
$2.14▼ -5.31%
Healthcare
Other
Volume 8.6K
Avg Volume (10D) 11.8K
Key Metrics & Fundamentals
Market Cap
$17.11M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.84 - 28.44
% vs 50 MA
-43.06%
% vs 200 MA
-67.91%
RSI-14
29.7
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.37
Free Cash Flow
-$2.68M
Gross Rev
$33,000
Gross Profit
-$89,000
EBITDA
-$6.01M
COGS
$122,000
Operating Exp
$6.62M
Operating Income
-$6.71M
EBIT
-$6.71M
Pretax Income
-$6.60M
Net Income
-$5.38M
EPS (Diluted)
-0.87
Price & Volume History
Loading chart…
Recent News
Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing
PR Newswire · Oct 22, 2026 4:20 PM ET
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
PR Newswire · Sep 22, 2026 7:55 AM ET
PAVmed (PAVM) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 8:58 PM ET
PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing Losses and Strategic Progress ...
GuruFocus.com · Aug 14, 2026 7:02 PM ET
PAVmed Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 4:59 PM ET
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
PR Newswire · Aug 14, 2026 8:00 AM ET
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
PR Newswire · Aug 13, 2026 8:00 AM ET
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
PR Newswire · Aug 5, 2026 8:36 AM ET
Lucid Diagnostics to Participate in Upcoming Investor Conferences
PR Newswire · Aug 4, 2026 8:30 AM ET
PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026
PR Newswire · Jul 31, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PAVM's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.